Emily Conley

Emily Drabant Conley currently works at Renasant Bio, Inc., as CEO, Chief Financial Officer, Secretary & Director, Renaissance Bio, as Chief Executive Officer from 2023, and TMRW Life Sciences, Inc., as Director.
Dr. Conley also formerly worked at Federation Bio, Inc., as Chief Executive Officer & Director, Nuvalent, Inc., as Independent Director from 2022 to 2025, Start Somewhere LLC, as Director, Ucsf Alliance Health Project, as Director, Medrio, Inc., as Director, and 23andMe, Inc., as Head-Business Development.
Dr. Conley received her undergraduate degree from Vanderbilt University and doctorate degree from Stanford University School of Medicine.